fda glp-1 crackdown news From Black Market to Biosimilar Battle: Chinese API Suppliers Pivot to Generics After FDA cracks down on online

Visual inspection Clear solution should remain clear: Any cloudiness = discard Particles floating = discard Color change = discard (especially important for copper peptides) Separation or layers = discard Exception: Some peptides may have slight natural color

- May 28, 2026 - CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members including the reintroduction of Zepbound (tirzepatide) as a covered medication

Oral hypoglycemic agent

Concerns usually arise from rare genetic conditions or unregulated, high-dose intravenous (IV) therapy

PubMed 12

In comparison, IGF-1 LR3 is not studied in humans, and there is a risk of dangerous side effects.